Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raymond Turner

Neurology Washington, DC Medical Doctor

NPI 1801977939 CMS profile 472061

4000 Reservoir Rd, Building D, Suite 177, Washington, DC 20057

Open in the dashboard

General payments

$152,225

175 records reported · program years 2019–2025

Research payments

$280,776

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$16,466,749 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Raymond Turner of Washington, DC is reported in the CMS Open Payments database as having received $152,225 across 175 general payments and $280,776 in research payments paid to them. Separately, studies naming them as principal investigator received $16,466,749 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $67,139 59
2024 General $55,632 66
2024 Research $181,340 2
2023 General $10,283 8
2023 Research $618 2
2022 General $6,993 6
2022 Research $93,798 3
2021 General $159 13
2020 General $7,806 4
2020 Research $5,020 3
2019 General $4,213 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raymond Turner
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Raymond Turner were reported at $67,139. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Raymond Turner Neurology median Middle half National median
2019 $4,213 $474 $118–$2,177 $163
2020 $7,806 $367 $82–$2,309 $114
2021 $159 $438 $104–$2,547 $132
2022 $6,993 $442 $103–$2,388 $149
2023 $10,283 $464 $119–$2,312 $160
2024 $55,632 $468 $119–$2,323 $164
2025 $67,139 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lilly USA, LLC $103,899 109 payments
  2. Eisai Inc. $30,424 31 payments
  3. Eli Lilly and Company $7,327 8 payments
  4. Biogen, Inc. $5,029 17 payments
  5. Sage Therapeutics, Inc. $3,000 1 payment
  6. Genentech, Inc. $1,980 2 payments
  7. F. Hoffmann-La Roche AG $160 2 payments
  8. Piramal Imaging Limited $157 2 payments
  9. Baxter Healthcare $131 1 payment
  10. Genentech USA, Inc. $92 1 payment
  11. Other $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $102,075 57 payments
  2. Consulting Fee $41,564 15 payments
  3. Travel and Lodging $5,018 40 payments
  4. Food and Beverage $3,378 49 payments
  5. Education $189 14 payments
Products named General payments · program years 2019–2025
  1. KISUNLA $100,594 99 payments
  2. Leqembi $13,253 9 payments
  3. NEURACEQ $157 2 payments
  4. TISSEEL $131 1 payment
  5. AMYVID $99 1 payment
  6. ADUHELM $43 1 payment
  7. API015 $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $277,776 9 payments
  2. Sage Therapeutics, Inc. $3,000 1 payment

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$7,623

Medicare's payments for the services billed

Medicare patients

31

Average age 79

Services billed

39

15 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Alzheimer's or dementia 61%
Arthritis 42%
Cancer 35%
Depression 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KISUNLA
  • Lilly USA, LLC $48,668
$48,668 — —
Leqembi
  • Eisai Inc. $3,724
$3,724 — —
NEURACEQ
  • Piramal Imaging Limited $151
$151 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record